NOTICE OF UPGRADE
Our websites will be unavailable between the hours of AEST 4AM September 17, 2022 and AEST 11PM on date September 18, 2022
SEARCH LISTED COMPANY
Any AUS or NZ company
SEARCH PRIVATE COMPANY
SEARCH FUNDS
Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
|
|
08 February 2025
Name: | HOLISTA COLLTECH LIMITED (HCT) | ||||||
ISIN: | AU000000HCT4 | ||||||
Date of Listing: | 26 February 2004 | ||||||
Former Names: |
|
Stock Exchange Status: (updated daily)
This entity is currently listed and quoted on the Australian Securities Exchange.Legal Status: (updated monthly)
ACN: 094 515 992ABN: 24 094 515 992
Registration Date: 18 September 2000
Capital Gains Tax (CGT) Status: (updated at least quarterly)
To crystallise a capital gain or capital loss on your securities in this entity, you are able to sell your securities on-market in the normal manner. If you determine that the market in your securities is illiquid and you still wish to crystallise a capital gain or loss, kindly contact deListed at admin@delisted.com.au for suggestions as to how you might proceed.
Updates, corrections, disagreements please email to admin@delisted.com.au
Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.
Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.
Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.
FROM | TO | |
HOLISTA COLLTECH LIMITED | 28/07/2009 | |
COLLTECH AUSTRALIA LIMITED | 28/07/2009 |
Computershare Perth
Level 17, 221 St Georges Terrace, Perth WA 6000
Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 3 9473 2500
RegistryWebsite RegistryEmail
Expand this box to read and print
The suspension of trading in the securities of Holista Colltech Limited is expected to be lifted from the commencement of trading on Friday, 24 May 2024 following the release by HCT of an announcement in relation to the payment terms of a Federal Court Order. | 23/05/2024 |
On 17 May 2024, an order for payment terms was received from the Federal Court Justice Sarah C Derrington. The Penalty is to be paid in two equal instalments of $900,000 each. The first instalment is due by 4:00 PM AEST on 18 November 2024. The second instalment is due by 4:00 PM AEST on 18 March 2025. No interest will be applied to these instalments if paid on time. If Holista fails to pay the first instalment by the specified date, the entire Penalty becomes immediately due and payable. Interest will accrue on the entire Penalty at the prescribed rate from the date the original judgment was entered, if there is default in payment. The Company is working on a strategic plan to fulfill its payment obligations as stipulated in the Court Order. | 23/05/2024 |
The company is requesting the continuation of its voluntary suspension for its ordinary shares, pending an announcement regarding payment terms with ASIC. The company submitted an affidavit to the Federal Court with its proposed payment plan, and a hearing was held on 8 May 2024. The decision has not yet been received, and Holista Colltech expects a decision by 22 May 2024. The suspension will continue until normal trading begins on 22 May 2024 and Holista Colltech makes an announcement to the market, stating it is not aware of any reason for the suspension. | 15/05/2024 |
The Annual General Meeting will be held at 11:00AM (AWST) on 31 May 2024, at Stantons International 40 Kings Park Road West Perth WA 6005. | 02/05/2024 |
The company lodges its Quarterly Activity and Cashflow Report. | 30/04/2024 |
Holista Colltech requests that the voluntary suspension continues until the earlier of commencing of normal trading on 15 May 2024 and when Holista Colltech makes an announcement to the market and requests the voluntary suspension be lifted. | 17/04/2024 |
Holista Colltech requests that the voluntary suspension continue until the earlier of commencing of normal trading on 17 April 2024 and when Holista Colltech makes an announcement to the market and requests the voluntary suspension be lifted | 03/04/2024 |
The company releases an Appendix 4G. | 02/04/2024 |
The company lodges its Annual Report to shareholders. | 02/04/2024 |
The securities of Holista Colltech Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of HCT, pending the release of an announcement regarding agreement of payment terms with ASIC following the outcome of the Federal Court Hearing judgment against HCT | 21/03/2024 |
The suspension of trading in the securities of Holista Colltech Limited will be lifted immediately, following the release by HCT of an announcement regarding an update to its "˜Collagen Market Update'. | 26/05/2021 |
The company provides additional information at the request of the ASX to the announcement released on 13 May 2021 entitled "Collagen Market Update". | 26/05/2021 |
The company would like to request for a further extension of the voluntary suspension be effective from 25 May 2021 until the earlier of the commencement of normal trading on Thursday 27 th May 2021 or the release of the announcement. | 25/05/2021 |
The company would like to request for a further extension of the voluntary suspension be effective from 24 May 2021 until the earlier of the commencement of normal trading on Tuesday 25th May 2021 or the release of the announcement to provide further information on the announcement previously made on 13 May 2021 titled 'Collagen Market Update'. | 24/05/2021 |
The company requests a further extension of the volulntary suspension of its securities until the earlier of the commencement of normal trading on Monday 24th May 2021 or the release of the announcement to provide further information on the announcement previously made on 13 May 2021 titled Collagen Market Update. | 20/05/2021 |
The securities of Holista Colltech Limited will be suspended from the commencement of quotation on Tuesday, 18 May 2021, under Listing Rule 17.2, at the request of HCT, pending the release of an announcement regarding an update to its "˜Collagen Market Update'. | 17/05/2021 |
The suspension of trading in the securities of Holista CollTech Limited will be lifted immediately following the release by HCT of an announcement regarding the M3 system. | 11/12/2020 |
Holista is authorised to immediately offer a "List N" certified solution to disinfect buildings amid a second wave of COVID-19 infections. Laboratoire M2 to supply its List N disinfectant, Bioesque, for use in the M3 system while Path Away is in the process of being registered on List N. Bioesque is a botanical 100% natural disinfectant similar to Path-Away. Products on List N meet U.S. EPA's criteria for use against SARS-CoV-2, which causes COVID-19. GICC has tested and certified Bioesque as the only alternative disinfectant to Path-Away that can be used in the M3 system. | 11/12/2020 |
The securities of Holista CollTech Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of HCT, pending the release of an announcement regarding the M3® system. | 10/12/2020 |
The suspension of trading in the securities of Holista CollTech Limited will be lifted immediately, following the release by HCT of an announcement regarding a subsidiary and strategic partnership. | 14/09/2020 |
Holista Sets Up North American operations and ends exclusive distribution agreement with Health Therapies LLC. Holista secures new partnership with Eight Mercatus USA, which is led by Mr Poonacha Machaiah. Mr Machaiah is the current CEO of The Chopra Foundation with long experience in the wellness space. Eight Mercatus Pte Ltd and Eight Mercatus (USA) Pte Ltd will be Holista's strategic business and marketing partners for the North America markets. | 14/09/2020 |
The company issues a notice of Proposed issue of Securities - HCT. | 14/09/2020 |
The securities of Holista CollTech Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of HCT, pending the release of an announcement regarding a subsidiary and strategic partnership. | 14/09/2020 |
securities reinstated | 08/11/2011 |
securities suspended pending an announcement | 07/11/2011 |
name changed from Colltech Australia Limited | 28/07/2009 |
The suspension of trading in the securities of Holista Colltech Limited is expected to be lifted from the commencement of trading on Friday, 24 May 2024 following the release by HCT of an announcement in relation to the payment terms of a Federal Court Order. | 23/05/2024 |
On 17 May 2024, an order for payment terms was received from the Federal Court Justice Sarah C Derrington. The Penalty is to be paid in two equal instalments of $900,000 each. The first instalment is due by 4:00 PM AEST on 18 November 2024. The second instalment is due by 4:00 PM AEST on 18 March 2025. No interest will be applied to these instalments if paid on time. If Holista fails to pay the first instalment by the specified date, the entire Penalty becomes immediately due and payable. Interest will accrue on the entire Penalty at the prescribed rate from the date the original judgment was entered, if there is default in payment. The Company is working on a strategic plan to fulfill its payment obligations as stipulated in the Court Order. | 23/05/2024 |
The company is requesting the continuation of its voluntary suspension for its ordinary shares, pending an announcement regarding payment terms with ASIC. The company submitted an affidavit to the Federal Court with its proposed payment plan, and a hearing was held on 8 May 2024. The decision has not yet been received, and Holista Colltech expects a decision by 22 May 2024. The suspension will continue until normal trading begins on 22 May 2024 and Holista Colltech makes an announcement to the market, stating it is not aware of any reason for the suspension. | 15/05/2024 |
The Annual General Meeting will be held at 11:00AM (AWST) on 31 May 2024, at Stantons International 40 Kings Park Road West Perth WA 6005. | 02/05/2024 |
The company lodges its Quarterly Activity and Cashflow Report. | 30/04/2024 |
Holista Colltech requests that the voluntary suspension continues until the earlier of commencing of normal trading on 15 May 2024 and when Holista Colltech makes an announcement to the market and requests the voluntary suspension be lifted. | 17/04/2024 |
Holista Colltech requests that the voluntary suspension continue until the earlier of commencing of normal trading on 17 April 2024 and when Holista Colltech makes an announcement to the market and requests the voluntary suspension be lifted | 03/04/2024 |
The company releases an Appendix 4G. | 02/04/2024 |
The company lodges its Annual Report to shareholders. | 02/04/2024 |
The securities of Holista Colltech Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of HCT, pending the release of an announcement regarding agreement of payment terms with ASIC following the outcome of the Federal Court Hearing judgment against HCT | 21/03/2024 |
The suspension of trading in the securities of Holista Colltech Limited will be lifted immediately, following the release by HCT of an announcement regarding an update to its "˜Collagen Market Update'. | 26/05/2021 |
The company provides additional information at the request of the ASX to the announcement released on 13 May 2021 entitled "Collagen Market Update". | 26/05/2021 |
The company would like to request for a further extension of the voluntary suspension be effective from 25 May 2021 until the earlier of the commencement of normal trading on Thursday 27 th May 2021 or the release of the announcement. | 25/05/2021 |
The company would like to request for a further extension of the voluntary suspension be effective from 24 May 2021 until the earlier of the commencement of normal trading on Tuesday 25th May 2021 or the release of the announcement to provide further information on the announcement previously made on 13 May 2021 titled 'Collagen Market Update'. | 24/05/2021 |
The company requests a further extension of the volulntary suspension of its securities until the earlier of the commencement of normal trading on Monday 24th May 2021 or the release of the announcement to provide further information on the announcement previously made on 13 May 2021 titled Collagen Market Update. | 20/05/2021 |
The securities of Holista Colltech Limited will be suspended from the commencement of quotation on Tuesday, 18 May 2021, under Listing Rule 17.2, at the request of HCT, pending the release of an announcement regarding an update to its "˜Collagen Market Update'. | 17/05/2021 |
The suspension of trading in the securities of Holista CollTech Limited will be lifted immediately following the release by HCT of an announcement regarding the M3 system. | 11/12/2020 |
Holista is authorised to immediately offer a "List N" certified solution to disinfect buildings amid a second wave of COVID-19 infections. Laboratoire M2 to supply its List N disinfectant, Bioesque, for use in the M3 system while Path Away is in the process of being registered on List N. Bioesque is a botanical 100% natural disinfectant similar to Path-Away. Products on List N meet U.S. EPA's criteria for use against SARS-CoV-2, which causes COVID-19. GICC has tested and certified Bioesque as the only alternative disinfectant to Path-Away that can be used in the M3 system. | 11/12/2020 |
The securities of Holista CollTech Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of HCT, pending the release of an announcement regarding the M3® system. | 10/12/2020 |
The suspension of trading in the securities of Holista CollTech Limited will be lifted immediately, following the release by HCT of an announcement regarding a subsidiary and strategic partnership. | 14/09/2020 |
Holista Sets Up North American operations and ends exclusive distribution agreement with Health Therapies LLC. Holista secures new partnership with Eight Mercatus USA, which is led by Mr Poonacha Machaiah. Mr Machaiah is the current CEO of The Chopra Foundation with long experience in the wellness space. Eight Mercatus Pte Ltd and Eight Mercatus (USA) Pte Ltd will be Holista's strategic business and marketing partners for the North America markets. | 14/09/2020 |
The company issues a notice of Proposed issue of Securities - HCT. | 14/09/2020 |
The securities of Holista CollTech Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of HCT, pending the release of an announcement regarding a subsidiary and strategic partnership. | 14/09/2020 |
securities reinstated | 08/11/2011 |
securities suspended pending an announcement | 07/11/2011 |
name changed from Colltech Australia Limited | 28/07/2009 |
Your browser may reflect a date of printing in American format.
re hct - what is its SRN number ? conran22 @hotmail.com | 04/06/2018 09:51:39 |
DATE | DIRECTOR | NUMBER | PRICE | AMOUNT |
---|---|---|---|---|
31/01/2019 | Rajen Marnickavasagar | 340,000 | $0.054 | $18,445 |
26/07/2012 | Warren Staude | 20,750 | $0.078 | $1,612 |
NAME | TITLE | DATE OF APPT |
---|---|---|
David Deloub | Non Exec Chairman | 06/04/2023 |
Loren King | Non Exec Director | 31/07/2021 |
Man Loong Leong | Executive Director, Interim CEO | 03/01/2025 |
Kwok Lai | Director | 21/03/2024 |
Jay Stephenson | Company Secretary |
Date of first appointment, title may have changed.
NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
---|---|---|---|
Rajen Marnickavasagar | Director, CEO | 10/07/2009 | 21/03/2024 |
Walter Joseph | Non Exec Director | 28/06/2021 | 06/04/2023 |
Daniel O'Connor | Non Exec Chairman | 29/11/2011 | 31/07/2021 |
Blair Michelson | Non Exec Director | 11/08/2020 | 28/06/2021 |
Chan Heng Fai | Non Exec Director | 01/07/2013 | 28/06/2021 |
Jonathan Pager | Director | 02/07/2020 | 11/08/2020 |
Brett Fraser | Non Exec Chairman | 21/02/2020 | 02/07/2020 |
Mark Collins | Non Exec Chairman, Non Exec Director | 01/08/2012 | 31/07/2013 |
Warren Staude | Non Exec Director | 01/02/2012 | 03/10/2012 |
Stuart Hazell | Non Exec Director | 14/10/2010 | 01/02/2012 |
Fathil Mohamed | Non Exec Director | 15/05/2008 | 01/12/2011 |
Paul Rengel | Non Exec Director | 02/10/2011 | |
Mick Aw | Non Exec Director | 07/08/2009 | 03/04/2011 |
Michael Pixley | Non Exec Director | 28/09/2006 | 25/11/2010 |
Ravindran Govindan | Non Exec Director | 30/05/2008 | 25/11/2010 |
Stephen Carter | Non Exec Director | 31/12/2005 | 13/11/2009 |
Gregg Mastroianni | Non Exec Director | 12/04/2007 | 01/06/2008 |
Anna Kluczewska | Non Exec Director | 06/08/2003 | 23/11/2007 |
John Snowden | Executive Director | 17/12/2002 | 30/11/2006 |
Michael Blakiston | Chairman | 27/11/2003 | 25/12/2005 |
Date of first appointment, title may have changed.
Contact Us | Financial Services Guide | Privacy Policy
This website is owned and operated by Investogain Pty Limited.
ABN 88 129 443 447 | AFSL 334036
Information provided is of a general nature and not for trading or advice.
Copyright © 2002-2025 Investogain Pty Limited. All rights reserved.